Research

Latest

Stem Cell Therapies - Research Update

When diagnosed, people with Parkinson’s have often had the disease for years and have lost over half of the dopamine producing cells in their brain. Now scientists are searching for a way to replace these nerve cells.
The Alex Flynn Award 2017 - our wonderful runners up

Our individual fundraisers are very special people and year on year never fail to inspire and amaze! They are our bedrock and we are so very grateful for their support and proud to call them part of our team...
Precision Medicine: Treating the Sub-groups of Parkinson's

The hunt for disease modifying treatments for Parkinson’s is gathering momentum and important shifts are taking place in the minds of clinicians, researchers and patients. One important development is that of 'precision medicine': targeting therapies to distinct subgroups based on specific symptoms or molecular features of the disease.
The Tom Isaacs Award 2018

Nominations are invited for this annual award co-created by the Van Andel Research Institute and The Cure Parkinson's Trust in memory of Tom Isaacs.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut.
Trials - Repurposed drugs

Our Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop, or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Apply for Funding
The NAC Trial - the facts
Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic?

A research paper published in the Journal of Parkinson's Disease (Spring 2016) discusses an impending clinical trial in Parkinson's disease (PD) using parthenogenetic stem cells.
CPT Co founder Tom Isaacs featured in the Journal of Parkinson's Disease

Science news

Read the latest Parkinson's science and research news here. Read more

Tom Isaacs and David Sangster - Advocacy & Teamwork

Our 2017 Annual Review

Find out more about our fantastic achievements over the year... Read more

Alison Anderson - Fundraiser of the Year 2017

We are delighted that Alison Anderson is the Alex Flynn Award winner of 2017! Following her diagnosis with Parkinson's, Alison was determined to move forward with optimism - so she took on an awesome and inspiring challenge... Read more

Leave a gift in your Will

A donation to The Cure Parkinson's Trust will make a huge difference to our research to slow, stop or even reverse Parkinson's. Read more